1Robert MK, Vivek NA, Stephen WC. Pulmonary complications of solid organ and hematopoietic stem cell transplantation. Am J Respir Crit Care Med,2004,170(1):22-48.
2Jason DC,Robert MK, Alberto P, et al. Clinical risk factors for primary graft failure following lung transplantation. Chest,2003,124(4) : 1232-1241.
3Trulock EP, Edwards LB, Taylor DO, et al. The registry of the international society for heart and lung transplantation:twentieth official adult lung and heart lung transplant report-2003. J Heart Lung Transplant,2003,22(6):625-635.
4Gao SZ, Chaparro SV, Perlroth M, et al. Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at stanford university. J Heart Lung Transplant, 2003,22 (5): 505-514.
5Tsai DE, Hardy CL, Tomaszewski JE, et al. Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients. Transplantation,2001,71(8) : 1076-1088.
6Haydar AA, Denton M0 West A,et al. Sirolimus-induced pneumonitis:three cases and a review of the literature. Am J Transplant, 2004,4( 1 ):137-139.
7Arguedas MR, Abrams GA, Krowka MJ, et al. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology, 2003,37(1) : 192-197.
8Kuo PC, Plotkin JS, Gaine S, et al. Portopulmonary hypertension and the liver transplant candidate. Transplantation, 1999, 67(8) : 1087-1093.
9Hopkins PM, Aboyoun CL, Chhajed PN. et al. Prospective analysis of 1,235 transbronchial lung biopsies in lung transplant recipients. J Heart Lung Transplant,2002,21(10):1062-1067.
10Estenne M, Maurer jR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant, 2002,21 ( 3 ) :297-310.
